PetMed Express Inc (PETS)
NASDAQHealth CareSpecialty RetailSnapshot 2026-09-04
$1.81-2.16%
Close 2026-09-04 · 1-day change
NASDAQHealth CareSpecialty RetailSnapshot 2026-09-04
QuarterlyIQ Insights · PETS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Mar 2026 | FY 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2013 | Mar 2012 | Mar 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 168.9 | 179.0 | 227.0 | 281.1 | 247.6 | 272.3 | 303.6 | 284.1 | 283.4 | 273.8 | 249.2 | 234.7 | 229.4 | 233.4 | 227.8 | 238.3 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 273.8 | — | — | — | — | — | — |
| Cost of Revenues | — | — | 157.8 | 202.4 | 171.1 | 195.3 | 219.3 | 202.9 | 188.1 | 176.0 | — | — | — | — | — | — |
| Gross Profit | 47.1 | 50.2 | 69.1 | 78.6 | 76.5 | 76.9 | 84.3 | 81.2 | 95.3 | 97.8 | 79.3 | 76.3 | 76.3 | 77.6 | 77.1 | 80.2 |
| Operating Expenses & Income | ||||||||||||||||
| Operating Income | (30.8) | (58.7) | (1.5) | (8.2) | 6.1 | 24.3 | 30.5 | 31.0 | 46.2 | 52.1 | 37.5 | 32.4 | 27.6 | 28.2 | 27.0 | 26.0 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest & Investment Income | — | — | — | — | 2.1 | 0.3 | 0.3 | 1.7 | 1.9 | 0.7 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 |
| Other Non-Operating Income / Expenses | 1.4 | 1.3 | 0.9 | 1.9 | 1.4 | (0.1) | 0.4 | 2.9 | 2.9 | 1.7 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 |
| Asset Writedown | — | 27.3 | 1.2 | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (29.3) | (57.4) | (0.6) | (6.3) | 7.4 | 24.2 | 31.0 | 33.9 | 49.1 | 53.8 | 37.9 | 32.6 | 27.8 | 28.4 | 27.3 | 26.4 |
| Income Tax Expense | (0.1) | (0.1) | 5.7 | 1.2 | 2.3 | 5.5 | 7.0 | 8.0 | 11.4 | 16.5 | 14.1 | 12.0 | 10.3 | 10.4 | 10.1 | 9.7 |
| Net Income | ||||||||||||||||
| Net Income | (29.3) | (57.3) | (6.3) | (7.5) | 5.1 | 18.7 | 23.9 | 25.9 | 37.7 | 37.3 | 23.8 | 20.6 | 17.5 | 18.0 | 17.2 | 16.7 |
| Per Share | ||||||||||||||||
| Basic EPS | (1.35) | (2.74) | (0.30) | (0.37) | 0.25 | 0.93 | 1.19 | 1.29 | 1.84 | 1.83 | 1.18 | 1.02 | 0.87 | 0.90 | 0.86 | 0.81 |
| Diluted EPS | (1.35) | (2.74) | (0.30) | (0.37) | 0.25 | 0.92 | 1.19 | 1.29 | 1.84 | 1.82 | 1.17 | 1.02 | 0.87 | 0.90 | 0.86 | 0.80 |
| Revenue per Share | 7.79 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | 0.60 | 1.20 | 1.20 | 1.12 | 1.08 | 1.06 | 0.85 | 0.76 | 0.72 | 0.68 | 0.66 | 1.60 | 0.53 |
| Basic Weighted Avg Shares | 21.7 | 20.9 | 20.6 | 20.4 | 20.3 | 20.2 | 20.1 | 20.0 | 20.5 | 20.3 | 20.2 | 20.1 | 20.0 | 0.0 | 19.9 | 20.6 |
| Diluted Weighted Avg Shares | 21.7 | 20.9 | 20.6 | 20.4 | 20.3 | 20.4 | 20.1 | 20.1 | 20.5 | 20.4 | 20.4 | 20.3 | 20.1 | 0.0 | 20.0 | 20.7 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (51.3) | 5.5 | (1.1) | 9.6 | 27.0 | — | — | — | — | — | — | — | — | — | — |
| EBIT | (30.8) | (58.7) | (1.5) | (8.2) | 6.1 | 24.3 | 30.5 | 31.0 | 46.2 | 52.1 | 37.5 | 32.4 | 27.6 | 28.2 | 27.0 | 26.0 |
| Effective Tax Rate | 0.2% | — | — | — | 31.0% | 22.6% | 22.7% | 23.7% | 23.2% | 30.7% | 37.2% | 36.8% | 37.2% | 36.7% | 37.1% | 36.8% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.